Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • vvvvvvrebel89130 vvvvvvrebel89130 Feb 28, 2013 3:18 PM Flag

    gsk failure impact on srpt

    1. no competition; clears the decks for srpt
    2. gsk's failure might make the fda more reluctant to approve aa without additional trials; fda doesn't want another failure on their hand

    looks like someone was caught off-guard by the gsk news even tho it is fairly old and wanted in, especitally in front of 2 presentations next week

    fda meeting held; awaiting minutes

    Sentiment: Strong Buy

 
SRPT
17.81+0.86(+5.07%)Jun 28 4:00 PMEDT